Jessica Palacio, 37, worked at a Miami-based clinical trial firm from 2013 to 2015, and after the trial, the drugmaker noticed inconsistencies and told the FDA.
During the summer of 2021, she was accused of a scheme to “falsify medical records to make it appear as though pediatric subjects made scheduled visits to UMR, received physical exams from a clinical investigator, and took study drugs as required, when in fact these events had not occurred,” according to a news release.
When an FDA investigator asked Ms. Palacio about her role, “she submitted a false affidavit claiming that she had performed a screening visit of a child subject when she had not,” according to the plaintiff’s case.
Ms. Palacio was found guilty of wire fraud and making a false statement to investigators, and a few months later, she faces 36 months in prison and three years of supervised release. Four co-conspirators have been sentenced for a similar amount of time of imprisonment and probation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.